MEDX
MEDX
Horizon Kinetics Medical ETF • Horizon Kinetics
$33.43 ▲ 1.39% (+0.46)
Managing Company Horizon Kinetics
Asset Under Management $18.13M
Inception Date Jan 27, 2023
Expense Ratio 0.85%
52w High $35.45
52w Low $24.79
Volume 4,128
Avg Volume 2,595
Asset Class Equity
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics.
Managing Company Horizon Kinetics
Asset Under Management $18.13M
Inception Date Jan 27, 2023
Expense Ratio 0.85%
52w High $35.45
52w Low $24.79
Volume 4,128
Avg Volume 2,595
Asset Class Equity
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 LLY | Eli Lilly and Company | 15.55% | 3.08K | $2.84M |
 ABBV | AbbVie Inc. | 8.03% | 7.03K | $1.47M |
 NVS | Novartis AG | 7.38% | 8.79K | $1.35M |
 AZN | AstraZeneca PLC | 5.88% | 5.26K | $1.07M |
 JNJ | Johnson & Johnson | 5.79% | 4.40K | $1.06M |
 BMY | Bristol-Myers Squibb Company | 4.88% | 15.35K | $891.41K |
 IONS | Ionis Pharmaceuticals, Inc. | 4.80% | 11.43K | $877.21K |
 ALNY | Alnylam Pharmaceuticals, Inc. | 4.22% | 2.27K | $771.14K |
 AMGN | Amgen Inc. | 4.15% | 2.16K | $758.40K |
 MRK | Merck & Co., Inc. | 4.04% | 6.15K | $738.23K |
 ALKS | Alkermes plc | 3.91% | 21.10K | $714.62K |
 PFE | Pfizer Inc. | 3.52% | 23.74K | $643.48K |
 GSK | GSK plc | 3.34% | 10.32K | $610.68K |
 CRSP | CRISPR Therapeutics AG | 3.01% | 9.67K | $549.89K |
 BIIB | Biogen Inc. | 2.80% | 2.86K | $511.29K |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.73% | 660 | $498.64K |
 BEAM | Beam Therapeutics Inc. | 1.46% | 8.79K | $266.37K |
 NTLA | Intellia Therapeutics, Inc. | 1.07% | 13.19K | $194.92K |
 VNDA | Vanda Pharmaceuticals Inc. | 0.95% | 23.74K | $173.75K |
 HLN | Haleon plc | 0.69% | 12.90K | $125.13K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Switzerland
United Kingdom Other
7.85%
IrelandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Switzerland United Kingdom Other
7.85% IrelandHoldings (Top 20)
LLY
Eli Lilly and Company
Weight: 15.55% Shares: 3.08K Value: $2.84M
ABBV
AbbVie Inc.
Weight: 8.03% Shares: 7.03K Value: $1.47M
NVS
Novartis AG
Weight: 7.38% Shares: 8.79K Value: $1.35M
AZN
AstraZeneca PLC
Weight: 5.88% Shares: 5.26K Value: $1.07M
JNJ
Johnson & Johnson
Weight: 5.79% Shares: 4.40K Value: $1.06M
BMY
Bristol-Myers Squibb Company
Weight: 4.88% Shares: 15.35K Value: $891.41K
IONS
Ionis Pharmaceuticals, Inc.
Weight: 4.80% Shares: 11.43K Value: $877.21K
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 4.22% Shares: 2.27K Value: $771.14K
AMGN
Amgen Inc.
Weight: 4.15% Shares: 2.16K Value: $758.40K
MRK
Merck & Co., Inc.
Weight: 4.04% Shares: 6.15K Value: $738.23K
ALKS
Alkermes plc
Weight: 3.91% Shares: 21.10K Value: $714.62K
PFE
Pfizer Inc.
Weight: 3.52% Shares: 23.74K Value: $643.48K
GSK
GSK plc
Weight: 3.34% Shares: 10.32K Value: $610.68K
CRSP
CRISPR Therapeutics AG
Weight: 3.01% Shares: 9.67K Value: $549.89K
BIIB
Biogen Inc.
Weight: 2.80% Shares: 2.86K Value: $511.29K
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 2.73% Shares: 660 Value: $498.64K
BEAM
Beam Therapeutics Inc.
Weight: 1.46% Shares: 8.79K Value: $266.37K
NTLA
Intellia Therapeutics, Inc.
Weight: 1.07% Shares: 13.19K Value: $194.92K
VNDA
Vanda Pharmaceuticals Inc.
Weight: 0.95% Shares: 23.74K Value: $173.75K
HLN
Haleon plc
Weight: 0.69% Shares: 12.90K Value: $125.13K